FDA Approves Dry AMD Treatment Option


Our Minnesota Retina Associates providers are happy to announce that for the first time, patients with advanced stages of dry age-related macular degeneration (AMD) may have access to a treatment option. It is the beginning of a new era for the treatment of a potentially blinding condition. The U.S. Food and Drug Administration (FDA) cleared […]

Read More